Results 121 to 130 of about 2,356,155 (301)
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Mode of access: Internet.Later proceedings published in: Michigtan state bar journal.1901 bound with: Michigan State Bar Association. Official proceedings of the ...
Michigan State Bar Association.
core
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
On bar recursion of types 0 and 1 [PDF]
For general information on bar recursion the reader should consult the papers of Spector [8], where it was introduced, Howard [2] and Tait [11]. In this note we shall prove that the terms of Godel's theory T (in its extensional version of Spector [8]
HELMUT SCHWICHTENBERG +1 more
core
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley +1 more source
Proceedings of the Southern New Hampshire Bar Association at its ... annual meeting.
Imprint varies.Mode of access: Internet.Merged with: Grafton and Coös Bar Association. Meeting. Proceedings of the Grafton and Coös Counties Bar Association, to form: Bar Association of the State of New Hampshire. Proceedings of the Bar Association of
Southern New Hampshire Bar Association.
core
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source

